SEARCH, Institute of HIV Research and Innovation, Bangkok, Thailand.
Department of Neurology and Center for Neuroepidemiology and Clinical Neurological Research, Yale University, New Haven, CT, USA.
Curr HIV/AIDS Rep. 2022 Jun;19(3):207-216. doi: 10.1007/s11904-022-00605-1. Epub 2022 May 10.
This review focuses on the cerebrospinal fluid (CSF) findings in connection to the central nervous system (CNS) reservoir in treatment-naïve and virally suppressed PLWH, followed by the findings in CSF HIV-1 escape and analytical treatment interruption studies.
Compared to chronic infection, initiating antiretroviral therapy (ART) during acute HIV-1 infection results in more homogeneous longitudinal benefits in the CNS. Viral variants in CSF HIV-1 escape are independently linked to infected cells from the systemic reservoir and in the CNS, highlighting the phenomenon as a consequence of different mechanisms. HIV-infected cells persist in CSF in nearly half of the individuals on stable ART and are associated with worse neurocognitive performance. Future studies should probe into the origin of the HIV-infected cells in the CSF. Examining the capacity for viral replication would provide new insight into the CNS reservoir and identify strategies to eradicate it or compensate for the insufficiency of ART.
本综述重点介绍了未经治疗和病毒抑制的 PLWH 中与中枢神经系统(CNS)储库相关的脑脊液(CSF)发现,随后介绍了 CSF HIV-1 逃逸和分析性治疗中断研究中的发现。
与慢性感染相比,在急性 HIV-1 感染期间开始抗逆转录病毒治疗(ART)会导致 CNS 更均匀的纵向获益。CSF HIV-1 逃逸中的病毒变异与来自系统储库和 CNS 的受感染细胞独立相关,突出了这一现象是不同机制的结果。在接受稳定 ART 的个体中,近一半的个体的 CSF 中仍存在 HIV 感染细胞,与较差的神经认知表现相关。未来的研究应该探讨 CSF 中 HIV 感染细胞的来源。检查病毒复制能力将为 CNS 储库提供新的见解,并确定消除它或弥补 ART 不足的策略。